Prophase labs announces pricing of public offering of common stock

Garden city, ny, jan. 18, 2021 (globe newswire) -- prophase labs, inc. (nasdaq: prph), a diversified medical science and technology company, announced today the pricing of an underwritten public offering of 3,000,000 shares of common stock at an offering price of $12.50 per share, for gross proceeds of $37,500,000. in addition, prophase has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares to cover over-allotments, if any. all of the shares are being offered by prophase.
PRPH Ratings Summary
PRPH Quant Ranking